Brii Biosciences Limited 13D and 13G filings for AN2 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:30 pm Sale |
2024-12-31 | 13G | AN2 Therapeutics, Inc. ANTX |
Brii Biosciences Limited | 927,201 3.100% |
-121,278 (-11.57%) |
Filing |
| 2023-02-13 4:45 pm Purchase |
2022-12-31 | 13G | AN2 Therapeutics, Inc. ANTX |
Brii Biosciences Limited | 1,048,479 5.400% |
1,048,479 (New Position) |
Filing |